Get started
Author

Valery P. Masenko

Observed names: V Masenko, V P Masenko, V. MASENKO, V. Masenko, V. P. MASENKO, V. P. Masenko, V.P. Masenko, V.P.  Masenko Masenko, Valery Masenko, Valery P. Massenko, В П Масенко
Observed institutions: King's College London, Centro Cardiologico Monzino, Ministry of Health of the Russian Federation, National Medical Research Center of Cardiology, University of Florence, Imperial College London
ORCID: 0000-0002-3840-687X
Observed ORCID: 0000-0002-3840-687X
OpenAlex ID: A5113782516
Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis
2014 · Alexandra V. Potekhina, Ekaterina Pylaeva, et al. · Atherosclerosis · 101
Hypotensive effect of Oxacom® containing a dinitrosyl iron complex with glutathione: Animal studies and clinical trials on healthy volunteers
2012 · Evgeny I. Chazov, Oleg V. Rodnenkov, et al. · Nitric Oxide · 90
Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
2016 · O I Afanasievа, E A Pylaeva, et al. · Terapevticheskii arkhiv · 16
[Effect of strict glycemic control on clinical state and course of the disease in patients with chronic heart failure and type II diabetes mellitus. Results of the REMBO "rational effective multicomponent therapy in the struggle against diabetes mellitus in patients with congestive heart failure" study].
2008 · Iu V Lapina, D N Filatov, et al. · PubMed · 9
The severity of internal carotid artery stenosis is associated with the circulating Th17 level
2020 · A.Yu. Filatova, A.V. Potekhina, et al. · Heliyon · 8
PDF
Low Blood Content of IL-10-Producing CD4+ T Cells as a Risk Factor for Progression of Coronary Atherosclerosis
2019 · A. Yu. Filatova, E. A. Pylaeva, et al. · Bulletin of Experimental Biology and Medicine · 8
In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein
2011 · Zufar A. Gabbasov, Sergei G. Kozlov, et al. · Canadian Journal of Physiology and Pharmacology · 8
[Rosuvastatin and fenofibrate in patients with diabetes and low high density lipoprotein cholesterol: comparison of changes of lipid levels and some markers of inflammation].
2009 · N V Polenova, N A Vaulin, et al. · PubMed · 8
Elevated Level of the Natriuretic Peptide Among Adult Population in Regions Participating in the ESSE-RF Study and Its Association With Cardiovascular Diseases and Risk Factors
2017 · S. A. Shalnova, A. E. Imaeva, et al. · Kardiologiia · 7
PDF
CD4+CD25highCD127low regulatory T cells in patients with stable angina and their dynamics after intracoronary sirolimus-eluting stent implantation
2011 · Alexandra V. Potekhina, Sergey I. Provatorov, et al. · Human Immunology · 7
Anaphylatoxins in dilated cardiomyopathy
1993 · M. SAMSONOV, E. NASSONOV, et al. · Journal of Internal Medicine · 7
[Effect of rosuvastatin therapy and myocardial revascularization on angiogenesis in coronary artery disease patients].
2007 · A E Semenova, I V Sergienko, et al. · PubMed · 6
[Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
2006 · I V Sergienko, E Iu Samoĭlenko, et al. · PubMed · 6
Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results
2016 · A.A. Skvortsov Skvortsov, D.E. Koshkina Koshkina, et al. · Kardiologiia · 5
Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome
2007 · Alexey A. Mazaev, Yaroslav A. Naimushin, et al. · Journal of Thrombosis and Thrombolysis · 5
P1743 The contribution of left atrial dysfunction to exercise intolerance in early heart failure with preserved left ventricular ejection fraction
2020 · A Ovchinnikov, A V Potekhina, et al. · European Heart Journal - Cardiovascular Imaging · 4
PDF
[Effect of bosentan on the clinical status and cellular immunity of patients with idiopathic pulmonary hypertension].
2013 · T V Martyniuk, K A Zykov, et al. · PubMed · 4
[Effector and regulatory blood lymphocyte subpopulations in stable coronary artery disease].
2014 · E A Pylaeva, A V Potekhina, et al. · PubMed · 3
[Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure].
2012 · S V Lakomkin, A A Skvortsov, et al. · PubMed · 3
[Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation].
2010 · M A Kuznetsova, N A Vaulin, et al. · PubMed · 3
[Short term simvastatin use in patients with heart failure of ischemic origin. Changes of blood lipids, markers of inflammation and left ventricular function].
2006 · I N Smetanina, N A Vaulin, et al. · PubMed · 3
[Dynamics of prostaglandin E content in patients with duodenal ulcer various treatment regimens].
1993 · M V Serebrianskaia, V P Masenko · PubMed · 3
Preprocedural high - sensitivity C-reactive protein (hsCRP) decrease during intensive atorvastatin therapy: the presumable impact on atherosclerosis progression after coronary stenting
2019 · A M Shchinova, G V Shlevkova, et al. · Terapevticheskii arkhiv · 2
PDF
Cardiac Cells in Regenerative Processes in Patients with Heart Failure Due to Ischaemic Heart Disease
2016 · O Stepanova, T Kulikova, et al. · Journal of Advances in Medicine and Medical Research · 2
[Study of thyroid function in patients with paroxysmal supraventricular tachycardia].
1989 · L N Vanin, A S Smetnev, et al. · PubMed · 2
Works count: 64
Citation count: 330
H-index: 8
I10-index: 3
Year
Topic
Type